Hypercalcemia in an Infant with Primary Hyperoxaluria Type 2: A Novel Association

Pankaj Singhania1, Arunava Ghosh1, Rana Bhattacharjee1

  • 1Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education and Research/SSKM Hospital, Kolkata, West Bengal, India.

PubMed

Insights

This study reports a rare case of hypercalcemia in an infant, linked to primary hyperoxaluria type 2, a metabolic disorder. This association between nephrocalcinosis, nephrolithiasis, and primary hyperoxaluria type 2 is unprecedented.

Area of Science:

  • Pediatric Nephrology
  • Medical Genetics
  • Metabolic Disorders

Background:

  • Hypercalcemia in infants has diverse causes and clinical presentations.
  • Nephrocalcinosis and nephrolithiasis are significant renal complications in infants.
  • Primary hyperoxaluria (PH) is a rare inherited metabolic disorder affecting the liver.

Observation:

  • A 9-month-old female infant presented with urinary tract infection and systemic illness.
  • Investigations revealed bilateral medullary nephrocalcinosis and hypercalcemia.
  • Genetic testing confirmed Primary Hyperoxaluria type 2 (PH-2).

Findings:

  • This case presents the first genetically confirmed association between Primary Hyperoxaluria type 2 and hypercalcemia.
  • The infant exhibited nephrocalcinosis and nephrolithiasis secondary to PH-2.
  • Genetic analysis identified pathogenic mutations in the infant and carrier status in the mother.

Implications:

  • This finding expands the known clinical spectrum of Primary Hyperoxaluria type 2.
  • Highlights the importance of considering rare metabolic disorders in infants with unexplained hypercalcemia and renal abnormalities.
  • Suggests a potential link between PH-2 and calcium dysregulation, warranting further investigation.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
167
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
4.6K
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
13
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
16
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
1.9K
Renal Regulation of Acid-Base Balance01:29

Renal Regulation of Acid-Base Balance

Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
482